| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 50,064 | 55,262 | 52,114 | 76,228 | | Cost of Revenue | 46,315 | 42,316 | 38,063 | 57,479 | | | Gross Profit | 3,749 | 12,946 | 14,051 | 18,749 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,408 | 17,590 | 18,150 | 21,721 | | Non Recurring |
-
| 189 | (189) | 21,631 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (14,411) | (4,833) | (3,910) | (24,603) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (711) | 8 | 46 | 63 | | Earnings Before Interest And Taxes | (14,370) | (4,825) | (3,864) | (24,540) | | Interest Expense | 232 | 241 | 1,232 | 416 | | Income Before Tax | (14,602) | (5,066) | (5,096) | (24,956) | | Income Tax Expense | 90 | (109) | 280 | 729 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,692) | (4,957) | (5,376) | (25,685) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,692) | (4,957) | (5,376) | (25,685) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,692) | ($4,957) | ($5,376) | ($25,685) |
|
0.51% Nasdaq 
Income Statement
